$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 2 3 4 5 6 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 344 | 0 | 5,434 | |
Jun 12 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Sell | S | 90.84 | 872 | 79,216 | 72,074 | 72.9 K to 72.1 K (-1.20 %) |
Jun 12 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Payment of Exercise | F | 90.27 | 2,855 | 257,721 | 72,946 | 75.8 K to 72.9 K (-3.77 %) |
Jun 12 2020 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Executive Chairman | Gift | G | 0.00 | 1,100 | 0 | 3,180,943 | 3.2 M to 3.2 M (-0.03 %) |
Jun 05 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Payment of Exercise | F | 92.62 | 1,768 | 163,752 | 64,677 | 66.4 K to 64.7 K (-2.66 %) |
Jun 05 2020 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Payment of Exercise | F | 92.62 | 1,768 | 163,752 | 47,730 | 49.5 K to 47.7 K (-3.57 %) |
May 22 2020 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and CEO | Gift | G | 0.00 | 20,918 | 0 | 135,243 | 114.3 K to 135.2 K (+18.30 %) |
May 22 2020 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and CEO | Gift | G | 0.00 | 20,918 | 0 | 109,625 | 130.5 K to 109.6 K (-16.02 %) |
May 07 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | M | 38.40 | 38,732 | 1,487,309 | 135,925 | |
May 07 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | M | 48.90 | 41,268 | 2,018,005 | 0 | |
May 07 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Sell | S | 92.00 | 80,000 | 7,360,104 | 65,822 | 145.8 K to 65.8 K (-54.86 %) |
May 07 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Buy | M | 38.40 | 38,732 | 1,487,309 | 145,822 | 107.1 K to 145.8 K (+36.17 %) |
May 07 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Buy | M | 48.90 | 41,268 | 2,018,005 | 107,090 | 65.8 K to 107.1 K (+62.70 %) |
Apr 30 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 93.18 | 3,724 | 347,012 | 48,767 | 52.5 K to 48.8 K (-7.09 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 1,974 | 0 | 43,027 | 41.1 K to 43 K (+4.81 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Grant | A | 0.00 | 1,974 | 0 | 10,615 | 8.6 K to 10.6 K (+22.84 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 1,974 | 0 | 7,020,399 | 7 M to 7 M (+0.03 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Option Exercise | A | 93.68 | 9,991 | 935,957 | 9,991 | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | OSBORN WILLIAM A | Director | Grant | A | 0.00 | 1,974 | 0 | 58,297 | 56.3 K to 58.3 K (+3.50 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Option Exercise | A | 93.68 | 9,030 | 845,930 | 9,030 | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | NOVAKOVIC PHEBE N | Director | Grant | A | 0.00 | 1,974 | 0 | 28,307 | 26.3 K to 28.3 K (+7.50 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Option Exercise | A | 93.68 | 8,454 | 791,971 | 8,454 | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | McKinstry Nancy | Director | Grant | A | 0.00 | 1,974 | 0 | 25,640 | 23.7 K to 25.6 K (+8.34 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | McDew Darren W | Director | Grant | A | 0.00 | 1,974 | 0 | 1,974 | 0 to 2 K |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Option Exercise | A | 93.68 | 9,671 | 905,979 | 9,671 | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Grant | A | 0.00 | 1,974 | 0 | 30,127 | 28.2 K to 30.1 K (+7.01 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | Kumbier Michelle | Director | Grant | A | 0.00 | 1,974 | 0 | 5,248 | 3.3 K to 5.2 K (+60.29 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | Blount Sally E. | Director | Grant | A | 0.00 | 1,974 | 0 | 28,240 | 26.3 K to 28.2 K (+7.52 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Option Exercise | A | 93.68 | 9,735 | 911,975 | 9,735 | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 1,974 | 0 | 46,887 | 44.9 K to 46.9 K (+4.40 %) |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Grant | A | 0.00 | 1,974 | 0 | 32,380 | 30.4 K to 32.4 K (+6.49 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Sell | S | 96.10 | 414 | 39,785 | 39,706 | 40.1 K to 39.7 K (-1.03 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Sell | S | 96.10 | 414 | 39,785 | 39,706 | 40.1 K to 39.7 K (-1.03 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 75.90 | 25,681 | 1,949,188 | 51,364 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,715 | 2,200,697 | 36,715 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 98.00 | 83,226 | 8,156,148 | 62,205 | 145.4 K to 62.2 K (-57.23 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 75.90 | 25,681 | 1,949,188 | 145,431 | 119.8 K to 145.4 K (+21.45 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,715 | 2,200,697 | 119,750 | 83 K to 119.8 K (+44.22 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 83,035 | 37 K to 83 K (+124.30 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 75.90 | 25,681 | 1,949,188 | 51,364 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,715 | 2,200,697 | 36,715 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 98.00 | 83,226 | 8,156,148 | 62,205 | 145.4 K to 62.2 K (-57.23 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 75.90 | 25,681 | 1,949,188 | 145,431 | 119.8 K to 145.4 K (+21.45 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,715 | 2,200,697 | 119,750 | 83 K to 119.8 K (+44.22 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 83,035 | 37 K to 83 K (+124.30 %) |
Apr 03 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Payment of Exercise | F | 78.91 | 1,368 | 107,949 | 52,491 | 53.9 K to 52.5 K (-2.54 %) |
Apr 03 2020 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Payment of Exercise | F | 78.91 | 1,048 | 82,698 | 40,120 | 41.2 K to 40.1 K (-2.55 %) |
Apr 03 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 78.91 | 365 | 28,802 | 65,822 | 66.2 K to 65.8 K (-0.55 %) |
Apr 03 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Grant | A | 0.00 | 1,659 | 0 | 66,187 | 64.5 K to 66.2 K (+2.57 %) |
Apr 02 2020 | ABT | ABBOTT LABORATORIE ... | Stratton John G | Director | Option Exercise | A | 0.00 | 399 | 0 | 5,069 | |
Apr 02 2020 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 99 | 0 | 7,897 | |
Apr 01 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 79.34 | 343 | 27,214 | 2,624 | 3 K to 2.6 K (-11.56 %) |
Apr 01 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 740 | 0 | 2,967 | 2.2 K to 3 K (+33.23 %) |
Mar 16 2020 | ABT | ABBOTT LABORATORIE ... | Boudreau Philip P | Vice President | Sell | S | 82.00 | 10,600 | 869,200 | 22,463 | 33.1 K to 22.5 K (-32.06 %) |
Mar 10 2020 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 82.00 | 8,248 | 676,336 | 68,696 | 76.9 K to 68.7 K (-10.72 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 1,972 | 156,163 | 17,921 | 19.9 K to 17.9 K (-9.91 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Grant | A | 0.00 | 5,188 | 0 | 19,893 | 14.7 K to 19.9 K (+35.28 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 5,243 | 415,193 | 64,523 | 69.8 K to 64.5 K (-7.52 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Grant | A | 0.00 | 23,828 | 0 | 69,766 | 45.9 K to 69.8 K (+51.87 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 5,909 | 467,934 | 62,811 | 68.7 K to 62.8 K (-8.60 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 4,436 | 0 | 68,720 | 64.3 K to 68.7 K (+6.90 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Sell | S | 77.89 | 1,356 | 105,619 | 169,372 | 170.7 K to 169.4 K (-0.79 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 6,710 | 531,365 | 170,728 | 177.4 K to 170.7 K (-3.78 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Payment of Exercise | F | 79.19 | 16,638 | 1,317,563 | 130,543 | 147.2 K to 130.5 K (-11.30 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Sell | S | 77.89 | 1,420 | 110,604 | 53,859 | 55.3 K to 53.9 K (-2.57 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 3,533 | 279,778 | 55,279 | 58.8 K to 55.3 K (-6.01 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Payment of Exercise | F | 79.19 | 46,827 | 3,708,230 | 3,182,043 | 3.2 M to 3.2 M (-1.45 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 4,176 | 330,697 | 73,891 | 78.1 K to 73.9 K (-5.35 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Sell | S | 77.89 | 666 | 51,875 | 62,920 | 63.6 K to 62.9 K (-1.05 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 7,736 | 612,614 | 63,586 | 71.3 K to 63.6 K (-10.85 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 4,153 | 328,876 | 20,670 | 24.8 K to 20.7 K (-16.73 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Grant | A | 0.00 | 11,865 | 0 | 24,823 | 13 K to 24.8 K (+91.57 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 77.89 | 2,001 | 155,858 | 37,019 | 39 K to 37 K (-5.13 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 6,936 | 549,262 | 39,020 | 46 K to 39 K (-15.09 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 77.89 | 1,208 | 94,091 | 151,896 | 153.1 K to 151.9 K (-0.79 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 14,280 | 1,130,833 | 153,104 | 167.4 K to 153.1 K (-8.53 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 77.89 | 999 | 77,812 | 103,493 | 104.5 K to 103.5 K (-0.96 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 12,279 | 972,374 | 104,492 | 116.8 K to 104.5 K (-10.52 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Sell | S | 77.89 | 1,781 | 138,722 | 45,460 | 47.2 K to 45.5 K (-3.77 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Payment of Exercise | F | 79.19 | 4,720 | 373,777 | 47,241 | 52 K to 47.2 K (-9.08 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 14,318 | 1,133,842 | 114,099 | 128.4 K to 114.1 K (-11.15 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Option Exercise | A | 87.72 | 114,940 | 10,082,537 | 114,940 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Grant | A | 0.00 | 18,855 | 0 | 75,801 | 56.9 K to 75.8 K (+33.11 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Option Exercise | A | 87.72 | 76,198 | 6,684,089 | 76,198 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Grant | A | 0.00 | 12,500 | 0 | 51,961 | 39.5 K to 52 K (+31.68 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | DALE MICHAEL D | Senior Vice Preside ... | Option Exercise | A | 87.72 | 83,818 | 7,352,515 | 83,818 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | DALE MICHAEL D | Senior Vice Preside ... | Grant | A | 0.00 | 13,750 | 0 | 37,697 | 23.9 K to 37.7 K (+57.42 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Option Exercise | A | 87.72 | 76,198 | 6,684,089 | 76,198 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Option Exercise | A | 87.72 | 76,198 | 6,684,089 | 76,198 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Grant | A | 0.00 | 12,500 | 0 | 78,067 | 65.6 K to 78.1 K (+19.06 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 87.72 | 132,182 | 11,595,005 | 132,182 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 21,683 | 0 | 116,771 | 95.1 K to 116.8 K (+22.80 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | A | 87.72 | 126,435 | 11,090,878 | 126,435 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Karam Sammy | Senior Vice Preside ... | Option Exercise | A | 87.72 | 83,818 | 7,352,515 | 83,818 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Option Exercise | A | 87.72 | 68,578 | 6,015,662 | 68,578 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | WOODGRIFT RANDEL WILLIAM | Senior Vice Preside ... | Grant | A | 0.00 | 11,250 | 0 | 58,812 | 47.6 K to 58.8 K (+23.65 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Option Exercise | A | 87.72 | 87,334 | 7,660,938 | 87,334 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Sell | S | 84.93 | 400 | 33,972 | 66,131 | 66.5 K to 66.1 K (-0.60 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Payment of Exercise | F | 87.45 | 780 | 68,211 | 66,531 | 67.3 K to 66.5 K (-1.16 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Moreland Mary K | Executive Vice Pres ... | Grant | A | 0.00 | 14,326 | 0 | 67,311 | 53 K to 67.3 K (+27.04 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 87.72 | 103,446 | 9,074,283 | 103,446 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 16,969 | 0 | 325,504 | 308.5 K to 325.5 K (+5.50 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | A | 87.72 | 130,298 | 11,429,741 | 130,298 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Grant | A | 0.00 | 21,374 | 0 | 167,384 | 146 K to 167.4 K (+14.64 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | A | 87.72 | 83,818 | 7,352,515 | 83,818 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 13,750 | 0 | 64,284 | 50.5 K to 64.3 K (+27.21 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | A | 87.72 | 76,198 | 6,684,089 | 76,198 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Grant | A | 0.00 | 12,500 | 0 | 87,035 | 74.5 K to 87 K (+16.77 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Option Exercise | A | 87.72 | 390,896 | 34,289,397 | 390,896 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | President and COO | Grant | A | 0.00 | 64,124 | 0 | 147,181 | 83.1 K to 147.2 K (+77.20 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Option Exercise | A | 87.72 | 82,757 | 7,259,444 | 82,757 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Wainer Andrea F | Executive Vice Pres ... | Grant | A | 0.00 | 13,575 | 0 | 53,715 | 40.1 K to 53.7 K (+33.82 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | A | 87.72 | 68,578 | 6,015,662 | 68,578 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 11,250 | 0 | 45,956 | 34.7 K to 46 K (+32.42 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | A | 87.72 | 114,940 | 10,082,537 | 114,940 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Grant | A | 0.00 | 18,855 | 0 | 75,297 | 56.4 K to 75.3 K (+33.41 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | A | 87.72 | 154,013 | 13,510,020 | 154,013 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Grant | A | 0.00 | 25,265 | 0 | 177,438 | 152.2 K to 177.4 K (+16.60 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Option Exercise | A | 87.72 | 87,628 | 7,686,728 | 87,628 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Grant | A | 0.00 | 14,375 | 0 | 71,322 | 56.9 K to 71.3 K (+25.24 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | A | 87.72 | 416,956 | 36,575,380 | 416,956 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Grant | A | 0.00 | 68,399 | 0 | 3,228,870 | 3.2 M to 3.2 M (+2.16 %) |